As the Sars-CoV2 pandemic continues to grow, researchers around the world are urgently seeking new treatments to prevent infection, cure those infected, or lessen the severity of the disease. Although there are several recently approved vaccines, clinical trials are underway to "re-use" drugs normally indicated for other diseases. This…

Purpose: Professionals of human resources (HR) use different criteria in practice than they verbalize. Thus, the aim of this research was to identify the implicit criteria used for the selection of high-potential employees in recruitment and development settings in the pharmaceutical industry. Design/methodology/approach: A semi-structured…

This article investigates the biopolitical dimensions that have grown out of the union between biocapitalism and current science education reform in the US. Drawing on science and technology study theorists, I utilize the analytics of promissory valuation and salvationary discourses to understand how scientific literacy in the neo-Sputnik era has…

This article reports that India's medical profession is in a crisis. For every 10,000 people in India there are only six doctors, compared with nearly 55 in the United States and nearly 21 in Canada. The problem is likely to get worse before it gets better. Professors are leaving medical schools for better-paying jobs in private hospitals and in…

Introduction: The pharmaceutical industry, by funding over 60% of programs in the United States and Canada, plays a major role in continuing medical education (CME), but there are concerns about bias in such CME programs. Bias is difficult to define, and currently no tool is available to measure it. Methods: Representatives from industry and…

Great Britain's Nuffield report and the United States' Millis report suggesting strategies for reform in pharmaceutical education and pharmacy practice are compared. (MSE)

Pfizer, Inc. (hereinafter Pfizer), a U.S.-based pharmaceutical company, states that it is committed to being an "exemplary corporate citizen" that is "dedicated to discovering and developing innovative medicines and making them available to people all around the world." Pfizer boasts about its philanthropic focus, yet, like any…